• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Decrease of normotest/thrombotest discrepancy in non-contacted coumarin plasma after glass or ellagic acid activation.

作者信息

Girolami A, Patrassi G, Burul A

出版信息

Blut. 1976 Jul;33(1):41-8. doi: 10.1007/BF01005211.

DOI:10.1007/BF01005211
PMID:974273
Abstract

Activation of coumarin plasmas in glass tubes for 60 min resulted in a clear shortening of Thrombotest clotting times. Normotest clotting times were shortened too but to a much lesser extent. As a consequence the Normotest (NT)/Thrombotest (TT) discrepancy which was quite large at 0 time, became progressively smaller. This phenomenon was observed both in undiluted and 6:10 diluted plasma. After ellagic acid activation a similar phenomenon was noted even though a less pronounced shortening of Thrombotest was noted. These data suggest that Thrombotest is very sensitive to contact phase and to factor VII activation and not to any coumarin-induced inhibitors.

摘要

相似文献

1
Decrease of normotest/thrombotest discrepancy in non-contacted coumarin plasma after glass or ellagic acid activation.
Blut. 1976 Jul;33(1):41-8. doi: 10.1007/BF01005211.
2
Glass activation-induced decrease or disappearance of normotest-thrombotest discrepancy in congenital coagulation disorders of the prothrombin complex.玻璃激活诱导的凝血酶原复合物先天性凝血障碍中正常凝血酶原时间-凝血酶时间差异的降低或消失。
Folia Haematol Int Mag Klin Morphol Blutforsch. 1977;104(2):283-93.
3
Normotest--thrombotest discrepancy in congenital coagulation disorders of the prothrombin complex and in coumarin-treated patients: a nonspecific phenomenon.凝血酶原复合物先天性凝血障碍及香豆素治疗患者中正常凝血试验与血栓形成试验的差异:一种非特异性现象。
Am J Clin Pathol. 1977 Jan;67(1):57-60. doi: 10.1093/ajcp/67.1.57.
4
Apparent "inhibition" as tested by means of the dilution curve system in patients with clotting defect due to liver damage.
Blut. 1977 Sep 29;35(3):247-52. doi: 10.1007/BF00999466.
5
The relationship between Normotest and Thrombotest in patients on oral anticoagulant therapy.口服抗凝治疗患者中正常凝血酶原时间测定与凝血酶时间测定的关系。
Scand J Haematol. 1977 Apr;18(4):333-6. doi: 10.1111/j.1600-0609.1977.tb01204.x.
6
[Hepato-quick--a new thromboplastin time system: a comparison with normotest and thrombotest (author's transl)].肝速凝——一种新的凝血酶原时间系统:与正常凝血时间测定法和血栓试验的比较(作者译)
Wien Klin Wochenschr. 1974 Oct 18;86(19):577-83.
7
[Quick's time and derived times in the study of the extrinsic course of the coagulation process. The PIVKA (protein induced by vitamin K absence or antagonists) in states of chronic disseminated intravascular coagulation].[凝血过程外源性途径研究中的奎克时间及衍生时间。慢性弥散性血管内凝血状态下的异常凝血酶原(维生素K缺乏或拮抗剂诱导蛋白)]
Quad Sclavo Diagn. 1974 Dec;10(4):463-73.
8
Determination of coagulation factors (II-VII-X) and kaolin partial thromboplastin time by the LKB 8600 Reaction Rate Analyser.使用LKB 8600反应速率分析仪测定凝血因子(II - VII - X)及高岭土部分凝血活酶时间。
Scand J Clin Lab Invest. 1977 Feb;37(1):15-20.
9
Thrombotest mixing experiments in congenital coagulation disorders of the prothrombin complex and in coumarin treated patients. An additional evidence against the presence of an inhibitor in the latter.凝血酶原复合物先天性凝血障碍患者及香豆素治疗患者的凝血酶试验混合实验。这是反对后者存在抑制剂的又一证据。
Folia Haematol Int Mag Klin Morphol Blutforsch. 1977;104(3):463-70.
10
Comments on the significance of differences between thrombotest and normotest in the study of coumarin plasma.关于凝血酶试验与正常凝血试验在香豆素血浆研究中差异的意义的评论
Haemostasis. 1989;19(4):241-4. doi: 10.1159/000217605.

引用本文的文献

1
Apparent "inhibition" as tested by means of the dilution curve system in patients with clotting defect due to liver damage.
Blut. 1977 Sep 29;35(3):247-52. doi: 10.1007/BF00999466.

本文引用的文献

1
Comparison of the thrombotest with the one-stage prothrombin time.凝血酶试验与一期凝血酶原时间的比较。
N Engl J Med. 1961 Dec 28;265:1286-9. doi: 10.1056/NEJM196112282652604.
2
Thrombotest. A new method for controlling anticoagulant therapy.凝血试验。一种控制抗凝治疗的新方法。
Lancet. 1959 Nov 7;2(7106):754-8. doi: 10.1016/s0140-6736(59)90857-8.
3
BEHAVIOUR OF FACTORS II, VII, IX AND X IN BLEEDING COMPLICATIONS DURING LONG-TERM TREATMENT WITH COUMARIN.香豆素长期治疗期间出血并发症中凝血因子II、VII、IX和X的行为
Thromb Diath Haemorrh. 1964 Jan 1;10:278-81.
4
THE THROMBOTEST REAGENT AND CHRISTMAS DISEASE.
Lancet. 1963 Sep 7;2(7306):522. doi: 10.1016/s0140-6736(63)90257-5.
5
Control of anticoagulant therapy. The use of new tests.抗凝治疗的控制。新检测方法的应用。
Arch Intern Med. 1963 Feb;111:248-58. doi: 10.1001/archinte.1963.03620260108019.
6
Studies regarding the effect of foreign-surface contact on the one-stage prothrombin time determination.关于异物表面接触对一期凝血酶原时间测定影响的研究。
Thromb Diath Haemorrh. 1966 May 15;15(3):442-50.
7
Kinetic aspects of the interaction of blood-clotting enzymes. VI. Localization of the site of blood-coagulation inhibition by the protein induced by vitamin K absence (PIVKA).血液凝固酶相互作用的动力学方面。VI. 维生素K缺乏诱导蛋白(PIVKA)对血液凝固抑制位点的定位
Thromb Diath Haemorrh. 1968 Nov 15;20(1):78-87.
8
Hypercoagulable state induced in humans by the intravenous administration of purified ellagic acid.静脉注射纯化的鞣花酸在人体内诱导的高凝状态。
Thromb Diath Haemorrh. 1967 Feb 28;17(1-2):165-75.
9
Congenital afibrinogenemia. A case report with some considerations on the hereditary transmission of this disorder.
Thromb Diath Haemorrh. 1971 Jun 30;25(3):460-8.
10
Ellagic acid induced thromboelastographic changes in the normal individual and in several coagulopathies.鞣花酸可引起正常个体及多种凝血障碍患者血栓弹力图的改变。
Haematol Lat. 1969 Apr-Jun;12(2):143-54.